HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Udai Banerji Selected Research

AT13148

1/2020Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulation.
1/2020First-in-Human Study of AT13148, a Dual ROCK-AKT Inhibitor in Patients with Solid Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Udai Banerji Research Topics

Disease

58Neoplasms (Cancer)
01/2022 - 10/2003
9Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 10/2005
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2015
6Breast Neoplasms (Breast Cancer)
04/2021 - 08/2007
6Disease Progression
01/2020 - 10/2015
6Melanoma (Melanoma, Malignant)
10/2017 - 04/2008
4Exanthema (Rash)
11/2020 - 02/2015
3Neutropenia
01/2022 - 12/2006
3Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 01/2019
3Fatigue
11/2020 - 05/2012
3Diarrhea
01/2020 - 12/2014
3Nausea
04/2017 - 01/2014
2Pleural Effusion (Pleural Effusions)
01/2022 - 01/2016
2Hypotension (Low Blood Pressure)
01/2020 - 01/2020
2Hyperglycemia
01/2020 - 01/2016
2Carcinoma (Carcinomatosis)
11/2019 - 05/2012
2Glioblastoma (Glioblastoma Multiforme)
08/2018 - 10/2017
2Thrombocytopenia (Thrombopenia)
04/2017 - 05/2012
1Febrile Neutropenia
01/2022
1Fever (Fevers)
11/2021
1Multiple Myeloma
11/2020
1Retinal Detachment (Retinal Detachments)
11/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2020
1Pneumonia (Pneumonitis)
01/2020
1Malignant Mesothelioma
01/2020
1Mesothelioma
01/2020
1Eye Diseases (Eye Disease)
01/2019
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2019
1Anorexia
04/2017
1Hyperbilirubinemia
04/2017
1Leukopenia
04/2017

Drug/Important Bio-Agent (IBA)

17Pharmaceutical PreparationsIBA
11/2020 - 09/2009
10Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2021 - 09/2012
10Biomarkers (Surrogate Marker)IBA
01/2020 - 10/2005
9Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2018 - 10/2003
8tanespimycin (17AAG)IBA
11/2018 - 11/2003
7Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2007
6capivasertibIBA
04/2021 - 07/2017
5Phosphotransferases (Kinase)IBA
04/2021 - 07/2017
5Carboplatin (JM8)FDA LinkGeneric
01/2020 - 12/2006
4Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
4PhosphoproteinsIBA
01/2022 - 01/2016
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2012
4Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2020 - 11/2017
3CreatinineIBA
11/2020 - 05/2012
3Estrogen ReceptorsIBA
01/2020 - 08/2014
3Cell-Free Nucleic AcidsIBA
07/2017 - 01/2012
2pembrolizumabIBA
01/2022 - 01/2020
2Cetuximab (Erbitux)FDA Link
10/2021 - 01/2020
2Fulvestrant (Faslodex)FDA Link
04/2021 - 01/2020
2RO5126766IBA
11/2020 - 09/2012
2Immunoconjugates (Immunoconjugate)IBA
01/2020 - 02/2016
2AT13148IBA
01/2020 - 01/2020
2Capsules (Microcapsules)IBA
01/2018 - 03/2010
2Phosphorylcholine (Phosphocholine)IBA
12/2017 - 11/2003
2vistusertibIBA
12/2017 - 08/2015
2Phospholipids (Phosphatides)FDA LinkGeneric
12/2017 - 11/2003
2Adenosine Triphosphate (ATP)IBA
12/2017 - 07/2017
2Anaplastic Lymphoma KinaseIBA
01/2017 - 01/2015
2Biological ProductsIBA
01/2016 - 01/2014
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2016 - 01/2016
2Pemetrexed (MTA)FDA Link
01/2016 - 01/2015
2AZD 6244IBA
02/2015 - 03/2010
2ErbB Receptors (EGF Receptor)IBA
01/2015 - 06/2013
25- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
08/2014 - 07/2013
2Histone Deacetylase InhibitorsIBA
08/2013 - 05/2012
2Histones (Histone)IBA
08/2013 - 05/2012
1guadecitabineIBA
01/2022
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
04/2021
1olaparibIBA
10/2020
1Messenger RNA (mRNA)IBA
01/2020
1Actin Depolymerizing Factors (Cofilins)IBA
01/2020
1EnzymesIBA
01/2020
1cyclopropapyrroloindoleIBA
01/2020
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2020
1AntibodiesIBA
01/2020
1PlatinumIBA
01/2020
1Gefitinib (Iressa)FDA Link
01/2020
1N,N-dimethylarginine (asymmetric dimethylarginine)IBA
01/2020
1Chimeric Antigen ReceptorsIBA
01/2020
12- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
01/2019
1TAS-116IBA
01/2019
1diglycidyl- (3- (3,3- bisphosphono- 3- hydroxypropylamino)- 2- hydroxypropyl)urazolIBA
01/2019
1Ado-Trastuzumab EmtansineIBA
01/2019
1trastuzumab duocarmazineIBA
01/2019
1Hormones (Hormone)IBA
01/2019
1SteroidsIBA
08/2018
1TabletsIBA
01/2018
1Mechanistic Target of Rapamycin Complex 1IBA
12/2017
1Paclitaxel (Taxol)FDA LinkGeneric
12/2017
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
11/2017
1SphingomyelinsIBA
10/2017
1propionylcarnitineIBA
10/2017
1CH 4987655IBA
10/2017
1Amino AcidsFDA Link
10/2017
1Phosphatidylcholines (Phosphatidylcholine)IBA
10/2017

Therapy/Procedure

17Therapeutics
11/2020 - 03/2010
9Drug Therapy (Chemotherapy)
01/2020 - 12/2006
2Precision Medicine
01/2017 - 09/2009
1Immunomodulation
01/2022